NCT06635564 Personalized ViscoElastic Testing-guided Bleeding Management In Liver Surgery, Neurosurgery and Obstetrics
| NCT ID | NCT06635564 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Vienna |
| Condition | Thrombelastography |
| Study Type | OBSERVATIONAL |
| Enrollment | 240 participants |
| Start Date | 2024-07-01 |
| Primary Completion | 2026-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 240 participants in total. It began in 2024-07-01 with a primary completion date of 2026-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The ClotPro analyzer is a new generation viscoelastic analyzer for the in vitro assessment of blood coagulation. This study aims to assess the agreement of ClotPro 6.0, ROTEM delta, and TEG 6s in three distinct cohorts: i) patients with liver disease undergoing liver surgery, ii) pregnant women undergoing elective cesarean section, and iii) patients undergoing elective intracranial neurosurgery. Further coagulation tests will be performed (standard laboratory coagulation tests, thrombin and plasmin generation tests) in an exploratory fashion to compare them with viscoelastic test results. The obtained test results will not result in any diagnostic or therapeutic consequences for patients included in this study.
Eligibility Criteria
Inclusion Criteria: 1. Vulnerable patient cohorts * Patients undergoing elective liver surgery defined as one of the following invasive procedures: * Liver resection (anatomic or non-anatomic segmental resection, right or left hepatectomy, right or left extended hepatectomy), * Orthotopic liver transplantation, * Pregnant women undergoing an elective caesarean section, and * Patients undergoing an elective intracranial neurosurgery. 2. Written informed consent Exclusion Criteria: none
Contact & Investigator
Johannes Gratz, PhD MD
PRINCIPAL INVESTIGATOR
Medical University of Vienna
Frequently Asked Questions
Who can join the NCT06635564 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Thrombelastography. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06635564 currently recruiting?
Yes, NCT06635564 is actively recruiting participants. Contact the research team at nikolaus.hofmann@meduniwien.ac.at for enrollment information.
Where is the NCT06635564 trial being conducted?
This trial is being conducted at Vienna, Austria.
Who is sponsoring the NCT06635564 clinical trial?
NCT06635564 is sponsored by Medical University of Vienna. The principal investigator is Johannes Gratz, PhD MD at Medical University of Vienna. The trial plans to enroll 240 participants.